Literature DB >> 7272705

Fluorimetric and microbiological assays of erythromycin concentrations in plasma and vaginal washings.

A Iliopoulou, R N Thin, P Turner.   

Abstract

Using a microbiological and a fluorimetric assay to determine penetration of erythromycin into vaginal fluids, concentrations were measured in plasma from nine men one hour after a single oral dose of erythromycin stearate 2 g and in vaginal washings and plasma samples taken simultaneously from 11 women two hours after the last dose of a 10-day course of erythromycin stearate (250 mg four times daily). Both assay methods gave accurate and reproducible results in plasma but only the fluorimetric method was capable of measuring concentrations of erythromycin in vaginal washings. The latter method had many advantages in estimating drug concentrations in body fluids such as vaginal washings and the results from it may provide an index of tissue penetration and of patient compliance in adhering to drug regimens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272705      PMCID: PMC1045938          DOI: 10.1136/sti.57.4.263

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  4 in total

1.  Fluorometric determination of erythromycin and erythromycin propionate in whole blood or plasma and correlation of results with microbiological assay.

Authors:  K Y Tserng; J G Wagner
Journal:  Anal Chem       Date:  1976-02       Impact factor: 6.986

2.  Micromethod for assaying serum levels of erythromycin.

Authors:  S C Bell; J W Hamman; W E Grundy
Journal:  Appl Microbiol       Date:  1969-01

3.  The diffusion and concentration of trimethoprim in human vaginal fluid.

Authors:  T A Stamey; M Condy
Journal:  J Infect Dis       Date:  1975-03       Impact factor: 5.226

4.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  Br J Vener Dis       Date:  1978-04
  4 in total
  5 in total

1.  Secretion of drugs into the human female genital tract.

Authors:  I G Salas-Herrera; P Turner; R M Pearson
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

2.  Pharmacokinetic interaction between theophylline and erythromycin.

Authors:  A Iliopoulou; M E Aldhous; A Johnston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

3.  Should erythromycin dose be altered in haemodialysis patients?

Authors:  A Iliopoulou; K Downey; D M Chaput de Saintonge; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Antiretroviral pharmacology in mucosal tissues.

Authors:  Corbin G Thompson; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

5.  Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.

Authors:  Richard G Brown; Julian R Marchesi; Yun S Lee; Ann Smith; Benjamin Lehne; Lindsay M Kindinger; Vasso Terzidou; Elaine Holmes; Jeremy K Nicholson; Phillip R Bennett; David A MacIntyre
Journal:  BMC Med       Date:  2018-01-24       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.